Low Birthweight and Risk of Type 2 Diabetes: a Mendelian Randomisation Study
Overview
Affiliations
Aims/hypothesis: Low birthweight has been associated with a high risk of type 2 diabetes mellitus in observational studies. However, it remains unclear whether this relation is causal.
Methods: The present study included 3627 individuals with type 2 diabetes and 12,974 control participants of European ancestry from the Nurses' Health Study and the Health Professionals Follow-Up Study. A genetic risk score (GRS) was calculated based on five low-birthweight-related single nucleotide polymorphisms (SNPs). We assessed the evidence for causality first by examining the association of the GRS and the individual SNPs with type 2 diabetes, and second by performing a Mendelian randomisation analysis to estimate the potentially causal effect size of low birthweight on type 2 diabetes.
Results: In a meta-analysis of the two studies, each 1 point increment in the GRS was associated with a 6% (95% CI 3%, 9%) higher risk of type 2 diabetes. CCNL1 rs900400 and 5q11.2 rs4432842 showed dose-response associations with risk of type 2 diabetes; the corresponding ORs and 95% CIs were 1.09 (1.03, 1.16) and 1.09 (1.02, 1.16), respectively. Furthermore, we observed an overall Mendelian randomisation OR of 2.94 (95% CI 1.70, 5.16; p < 0.001) for type 2 diabetes per 1 SD lower genetically determined birthweight.
Conclusions/interpretation: A genetically lowered birthweight was associated with increased susceptibility to type 2 diabetes. Our findings support a potential causal relation between birthweight and risk of type 2 diabetes, providing new evidence to support the role of intrauterine exposures in the pathogenesis of type 2 diabetes.
Cedars M, Root K, Akhaphong B, Beetch M, Miles A, Regal R Physiol Rep. 2025; 13(3):e70222.
PMID: 39903552 PMC: 11792987. DOI: 10.14814/phy2.70222.
Cao L, Wen Y, Fan K, Wang Q, Zhang Y, Li Z Lipids Health Dis. 2024; 23(1):97.
PMID: 38566047 PMC: 10986016. DOI: 10.1186/s12944-024-02087-z.
Celind J, Bygdell M, Bramsved R, Martikainen J, Ohlsson C, Kindblom J Diabetologia. 2024; 67(5):874-884.
PMID: 38386069 PMC: 10954927. DOI: 10.1007/s00125-024-06101-y.
Power G, Sanderson E, Pagoni P, Fraser A, Morris T, Prince C Eur J Epidemiol. 2023; 39(5):501-520.
PMID: 37938447 PMC: 7616129. DOI: 10.1007/s10654-023-01032-1.
BMI change during childhood, DNA methylation change at TXNIP, and glucose change during midlife.
Ma H, Wang X, Liang Z, Li X, Heianza Y, He J Obesity (Silver Spring). 2023; 31(8):2150-2158.
PMID: 37415079 PMC: 10524171. DOI: 10.1002/oby.23806.